CTICU Device Study CRUISE

Launched by HERNANDO GOMEZ · Feb 13, 2025

Keywords

ClinConnect Summary

The CTICU Device Study, also known as CRUISE, is a clinical trial that aims to evaluate three new devices designed to monitor important heart information in patients who have just undergone open heart surgery. These devices—ClearSight, CareTaker, and CNAP—are all approved by the FDA and can measure blood pressure and the amount of blood the heart pumps with each beat. The main goal of this study is to find out which of these devices provides the most accurate data without being invasive, meaning they don’t require any surgical procedures to use. This information could help doctors better care for patients while reducing risks associated with traditional monitoring methods.

To be eligible for this study, participants must be adults aged 18 years or older who have recently had cardiac surgery and are admitted to the Cardiothoracic Intensive Care Unit (CTICU). However, certain patients are excluded, such as those who have specific heart devices or conditions that could affect the study’s results. For those who participate, they can expect to have their heart data monitored using these new devices, and their information will help improve future patient care. It's also important to note that this study is not yet recruiting participants, so no one can join at this time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (18 years and older)
• • Male and female patients following cardiac surgery admitted to the CTICU with or without a pulmonary artery catheter
• Exclusion Criteria:
• • Subjects whose sternum remains open post-surgery and/or the presence of a LV ventricular assist device.
• • Presence of a any ventricular assist device, ECMO, Impella, durable LVAD, or central L/RVAD.
• • Spontaneous breathing activity upon coming out of the operating room (i.e., patients extubated in the operating room).
• • Presenting chronic atrial fibrillation, refractory acute atrial fibrillation to medical therapy or frequent extra-systoles.
• • Children will be excluded from this study. The hospital unit where all subjects will be recruited is for adults' (ages 18 and up) only. Gender, racial and ethnic sub groups will not be explicitly excluded.